The Haematology and Oncology department at GOSH is uniquely set up to treat the rarest and most complex forms of paediatric cancer.
Our overall haematology and oncology survival rates are comparable to the best results internationally. Our ALL studies include the best 5 year survival rates of of any large published series at 94.1%.
The Haematology and Oncology department at GOSH provides a comprehensive service for the diagnosis and management of childhood leukaemia and solid tumours. Our world-leading teams are also able to offer a second opinion service for clinicians from around the world.
The service treats approximately 450 patients each year, accounting for about 28% of national childhood cancer cases. We provide tertiary cancer care along the disease pathway and serve as the principal treatment centre for children and young people diagnosed with a number of different malignant and non-malignant oncological and haematological diagnoses.
Conditions we treat
- Acute lymphoblastic leukaemia
- Acute myeloid leukaemia
- Chronic myelogenous leukaemia
- Juvenile myelomonocytic leukaemia
- Haemophagocytic lymphohistiocytosis
- Non-Hodgkin’s lymphoma